Status:
RECRUITING
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Lead Sponsor:
AbbVie
Conditions:
Non-Segmental Vitiligo (NSV)
Alopecia Areata
Eligibility:
All Genders
12+ years
Brief Summary
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppur...
Eligibility Criteria
Inclusion
- Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS)
- Participants Ability to understand study questionnaires, with caregiver support as required for adolescents
Exclusion
- Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study)
- Unable or unwilling to comply with study requirements and PRO collection
Key Trial Info
Start Date :
September 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
2795 Patients enrolled
Trial Details
Trial ID
NCT07136467
Start Date
September 2 2025
End Date
August 1 2027
Last Update
February 13 2026
Active Locations (116)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Britanico de Buenos Aires /ID# 278940
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina, 1280
2
Buenos Aires Skin /ID# 277637
Buenos Aires, Argentina, 1055
3
Centro de Investigacion y Prevencion Cardiovascular (CIPREC) /ID# 277634
Buenos Aires, Argentina, 1061
4
Hospital Italiano de Buenos Aires /ID# 277636
Buenos Aires, Argentina, 1181